There are 2949 resources available
Emergence of neuroendocrine prostate cancer and the clinical relevance of tumour evolution
Presenter: Charles Ryan
Session: Unlocking precision medicine for metastatic prostate cancer
Resources:
Slides
Webcast
Selection strategies for immunotherapy in prostate cancer
Presenter: Susan Slovin
Session: Unlocking precision medicine for metastatic prostate cancer
Resources:
Slides
Webcast
Clinical and molecular characteristics of resistance to immunotherapy
Presenter: Thomas Gajewski
Session: Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
Resources:
Slides
Webcast
Future combinations: Intralesional and other immunotherapy combinations
Presenter: Olivier Michielin
Session: Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
Resources:
Slides
Webcast
Future strategies: Sequencing versus combinations in targeted and immune therapy
Presenter: Paolo Ascierto
Session: Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
Resources:
Slides
Webcast
Management and learnings from toxicity?
Presenter: Caroline Robert
Session: Management of melanoma in 2030: Toxicity, resistance, best biomarkers and next steps
Resources:
Slides
Webcast
Using humanised mice to study immune-cancer interactions
Presenter: Anthony Rongvaux
Session: Preclinical models for unanswered clinical questions
Resources:
Slides
Webcast
The role of stem cells in cancer prevention and therapies
Presenter: Eduard Batlle
Session: Preclinical models for unanswered clinical questions
Resources:
Slides
Webcast
Intravital imaging for insights into cancer cell behaviour in real time
Presenter: Jacco van Rheenen
Session: Preclinical models for unanswered clinical questions
Resources:
Slides
Webcast